-
1Dissertation/ Thesis
المؤلفون: Pavlović, Vedrana
المساهمون: Tomaš, Ilijan
مصطلحات موضوعية: Kolorektalni karcinom, preživljenje bez progresije bolesti, ukupno preživljenje, Colorectal neoplasms, progression-free survival, overall survival, BIOMEDICINA I ZDRAVSTVO. Temeljne medicinske znanosti, BIOMEDICINE AND HEALTHCARE. Basic Medical Sciences
وصف الملف: application/pdf
Relation: https://repozitorij.unios.hr/islandora/object/mefos:1873; https://urn.nsk.hr/urn:nbn:hr:152:725038; https://repozitorij.unios.hr/islandora/object/mefos:1873/datastream/PDF
-
2
المؤلفون: Ban, Marija, Strikić, Ante, Petrić Miše, Branka, Vrdoljak, Eduard
المصدر: Liječnički vjesnik
Volume 141
Issue 1-2مصطلحات موضوعية: TUMORI DOJKE – farmakoterapija, metabolizam, patologija, smrtnost, HORMONSKI OVISNI TUMORI – farmakoterapija, metabolizam, patologija, smrtnost, PROTUTUMORSKI LIJEKOVI – farmakologija, neželjeni učinci, terapijska primjena, RECEPTOR ERBB-2 – metabolizam, CIKLIN OVISNA KINAZA 4 – antagonisti i inhibitori, metabolizam, CIKLIN OVISNA KINAZA 6 – antagonisti i inhibitori, metabolizam, AROMATOZNI INHIBITORI – terapijska primjena, FULVESTRANT – terapijska primjena, INHIBITORI PROTEINSKE KINAZE – neželjeni učinci, terapijska primjena, TUMORSKE METASTAZE, PREŽIVLJENJE BEZ PROGRESIJE BOLESTI, tumori dojke, hormonski ovisni tumori, protutumorski lijekovi, receptor erbb-2, ciklin ovisna kinaza 4, ciklin ovisna kinaza 6, aromatozni inhibitori, fulvestrant, inhibitori proteinske kinaze, tumorske metastaze, preživljenje bez progresije bolesti, BREAST NEOPLASMS – drug therapy, metabolism, mortality, pathology, NEOPLASMS, HORMONE-DEPENDENT – drug therapy, metabolism, mortality, pathology, ANTINEOPLASTIC AGENTS – adverse effects, pharmacology, therapeutic use, RECEPTOR, ERBB-2 – metabolism, CYCLIN-DEPENDENT KINASE 4 – antagonists and inhibitors, metabolism, CYCLIN-DEPENDENT KINASE 6 – antagonists and inhibitors, metabolism, AROMATOZNI INHIBITORI – therapeutic use, FULVESTRANT – therapeutic use, PROTEIN KINASE INHIBITORS – adverse effects, therapeutic use, NEOPLASM METASTASIS, PROGRESSION-FREE SURVIVAL
وصف الملف: application/pdf
-
3Dissertation/ Thesis
المؤلفون: Cini Tešar, Eleonora
المساهمون: Đorđević, Gordana
مصطلحات موضوعية: BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Onkologija, BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Oncology, Patologija. Klinička medicina, Pathology. Clinical medicine, info:eu-repo/classification/udc/616(043.3), BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Patologija, BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Pathology, karcinom prostate, radioterapija, imunohistokemija, p53, bcl-2, nfκb, Cr -1, Ki67, prognostički rezultat, preživljenje bez progresije bolesti, prostate cancer, radiotherapy, immunohistochemistry, prognostic score, progression-free survival
وصف الملف: application/pdf
Relation: https://www.unirepository.svkri.uniri.hr/islandora/object/medri:8527; https://urn.nsk.hr/urn:nbn:hr:184:681377; https://www.unirepository.svkri.uniri.hr/islandora/object/medri:8527/datastream/PDF
-
4
المؤلفون: Ivan Krečak, Sandra Bašić-Kinda, Dino Dujmović, Ida Hude, Ivo Radman-Livaja, Klara Dubravčić, Koraljka Gjadrov Kuveždić, Ivana Ilić, Igor Aurer
المصدر: Liječnički vjesnik
Volume 139
Issue 7-8مصطلحات موضوعية: Kronična limfocitna leukemija – farmakoterapija, komplikacije, Vidarabin – analozi i derivati, način uporabe i doziranje, nuspojave, terapijska primjena, Ciklofosfamid – način uporabe i doziranje, nuspojave, terapijska primjena, Rituksimab – način uporabe i doziranje, nuspojave, terapijska primjena, Protutumorski lijekovi – način uporabe i doziranje, nuspojave, terapijska primjena, Kombinirani protutumorski kemoterapijski protokoli – način uporabe i doziranje, nuspojave, terapijska primjena, Ishod liječenja, Indukcija remisije, Preživljenje bez progresije bolesti, Leukemia, lymphocytic, chronic, B-cell – complications, drug therapy, Vidarabine – administration and dosage, adverse effects, analogs and derivatives, therapeutic use, Cyclophosphamide – administration and dosage, adverse effects, therapeutic use, Rituximab – administration and dosage, adverse effects, therapeutic use, Antineoplastic agents – administration and dosage, adverse effects, therapeutic use, Antineoplastic combined chemotherapy protocols – administration and dosage, adverse effects, therapeutic use, Treatment outcome, Remission induction, Disease-free survival
وصف الملف: application/pdf
-
5Electronic Resource
Additional Titles: Role of CDK4/6 inhibitors in metastatic hormon positive HER2 negative breast cancer treatment
المؤلفون: Marija Ban, Ante Strikić, Branka Petrić Miše, Eduard Vrdoljak
المصدر: Liječnički vjesnik; ISSN 0024-3477 (Print); ISSN 1849-2177 (Online); Volume 141; Issue 1-2
مصطلحات الفهرس: TUMORI DOJKE – farmakoterapija, metabolizam, patologija, smrtnost; HORMONSKI OVISNI TUMORI – farmakoterapija, metabolizam, patologija, smrtnost; PROTUTUMORSKI LIJEKOVI – farmakologija, neželjeni učinci, terapijska primjena; RECEPTOR ERBB-2 – metabolizam; CIKLIN OVISNA KINAZA 4 – antagonisti i inhibitori, metabolizam; CIKLIN OVISNA KINAZA 6 – antagonisti i inhibitori, metabolizam; AROMATOZNI INHIBITORI – terapijska primjena; FULVESTRANT – terapijska primjena; INHIBITORI PROTEINSKE KINAZE – neželjeni učinci, terapijska primjena; TUMORSKE METASTAZE; PREŽIVLJENJE BEZ PROGRESIJE BOLESTI, BREAST NEOPLASMS – drug therapy, metabolism, mortality, pathology; NEOPLASMS, HORMONE-DEPENDENT – drug therapy, metabolism, mortality, pathology; ANTINEOPLASTIC AGENTS – adverse effects, pharmacology, therapeutic use; RECEPTOR, ERBB-2 – metabolism; CYCLIN-DEPENDENT KINASE 4 – antagonists and inhibitors, metabolism; CYCLIN-DEPENDENT KINASE 6 – antagonists and inhibitors, metabolism; AROMATOZNI INHIBITORI – therapeutic use; FULVESTRANT – therapeutic use; PROTEIN KINASE INHIBITORS – adverse effects, therapeutic use; NEOPLASM METASTASIS; PROGRESSION-FREE SURVIVAL, text, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion
URL:
https://hrcak.srce.hr/218766 https://hrcak.srce.hr/file/319312
info:eu-repo/semantics/altIdentifier/doi/10.26800/LV-141-1-2-6